| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Internal Medicine and Pathology, University of Virginia School of Medicine, Charlottesville, Virginia 22908 [M. E. W.]; Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45267 [S. H. S.]; and the Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 [C. L. R., A. A.]
The chromosome 11q13 bcl-1 locus is rearranged in the majority of centrocytic lymphomas, a CD5-positive B-cell non-Hodgkins lymphoma, as a result of reciprocal translocation with the 14q32 immunoglobulin heavy chain genes. Although several 11q13 bcl-1 breakpoint sites have been characterized, a postulated bcl-1 oncogene was not identified. Recently, however, a gene encoding cyclin D1, designated PRAD1, was proposed as a candidate bcl-1 oncogene; accumulated evidence now indicates this gene is bcl-1. To further characterize 11q13 breakpoints in B-cell neoplasms, we analyzed 26 centrocytic lymphomas and 68 other B-cell cancers by Southern blot using a panel of breakpoint probes spanning 110 kilobases of the bcl-1 and PRAD1 loci. Nineteen centrocytic cases (73%) showed rearrangement, 15 at bcl-1 breakpoint sites and 5 at PRAD1 sites. One case was rearranged at both bcl-1 and PRAD1 loci. All but the latter case showed comigration of rearranged bcl-1 or PRAD1 bands and immunoglobulin heavy chain joining gene bands, consistent with the t(11;14). bcl-1 rearrangement was present in only one of 68 noncentrocytic B-cell neoplasms; none showed PRAD1 rearrangement. Thus, bcl-1 and PRAD1 rearrangement is strongly associated with centrocytic lymphoma, providing a useful molecular marker for classifying this subtype of lymphoma and suggesting an important role for PRAD1 cyclin D1 in the pathogenesis of this neoplasm.
This article has been cited by other articles:
|
|
 |
|
  E. Peponi, E. Drakos, G. Reyes, V. Leventaki, G. Z. Rassidakis, and L. J. Medeiros Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma Am. J. Pathol., December 1, 2006; 169(6): 2171 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fernandez, E. Hartmann, G. Ott, E. Campo, and A. Rosenwald Pathogenesis of Mantle-Cell Lymphoma: All Oncogenic Roads Lead to Dysregulation of Cell Cycle and DNA Damage Response Pathways J. Clin. Oncol., September 10, 2005; 23(26): 6364 - 6369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Thomazy, R. Luthra, M. O. Uthman, P. J.A. Davies, and L. J. Medeiros Determination of Cyclin D1 and CD20 mRNA Levels by Real-Time Quantitative RT-PCR from Archival Tissue Sections of Mantle Cell Lymphoma and Other Non-Hodgkin's Lymphomas J. Mol. Diagn., November 1, 2002; 4(4): 201 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-X. Yan, H. Nakagawa, M.-H. Lee, and A. K. Rustgi Transforming Growth Factor-alpha Enhances Cyclin D1 Transcription through the Binding of Early Growth Response Protein to a cis-Regulatory Element in the Cyclin D1 Promoter J. Biol. Chem., December 26, 1997; 272(52): 33181 - 33190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Amrein and D. J. Weissman Case 43-1994- A 52-Year-Old Woman with Weakness, Diarrhea, and Diffuse Lymphadenopathy N. Engl. J. Med., December 8, 1994; 331(23): 1576 - 1583. [Full Text]
|
|
|
|
 |
|
 M. E. Williams, M. J. Gaffey, L. M. Weiss, S. P. Wilczynski, E. Schuuring, and P. A. Levine Chromosome 11Q13 Amplification in Head and Neck Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, November 1, 1993; 119(11): 1238 - 1243. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
